Protein Kinase Inhibitors

1. Kinase Inhibitors: An Overview2. Protein Kinase Inhibitors and cancer targeted therapy3. Drug discovery for cancer therapy with special reference to inhibitors of protein kinase pathway4. An insight on PI3K/Akt/mTOR inhibitors in cancer: opportunity and translational perspectives5. Recent advances in the therapeutic development of ERK inhibitors6. Emerging small-molecule inhibitors of ATM kinase targeting cancer therapy7. Targeting Pyruvate Kinase M2 Signaling for Development of Effective Cancer Therapy 8. Serum and glucocorticoid-regulated kinase 1: A potential target for anticancer therapy9. AKT inhibitors in cancer therapy10. Aurora kinase: An emerging potential target in therapeutics11. The Retroactive and Future Potentials of Aurora Kinases in the Treatment of Cancer12. Targeting the altered tyrosine kinases in colorectal cancer: from inhibitors to drugs13. PTEN-induced kinase1 (PINK1): Structure, Functions and Role in Human Disease14. Rho associated protein kinase 1 and 2 (ROCK1&ROCK2) as a potential emerging therapeutic drug target in Alzheimer's disease15. PDK inhibitors as therapeutic agents: An Overview16. Polo-like kinases (PLKs): an antimitotic target17. Src Kinase: An Attractive Therapeutic Target for Prostate Cancer 18. Kinase inhibition in Alzheimer's disease19. Therapeutic Targeting of Glycogen Synthase Kinase-3: Strategy to address neurodegenerative diseases20. Microtubule Affinity Regulating Kinase 4: a potential drug target from cancers to neurodegenerative diseases21. Receptor tyrosine kinase-like orphan receptors ROR1/2: Insights into the mechanism of action, inhibition, and therapeutic potentialIndrakant22. Therapeutic Potential of Leucine Rich Repeat Kinase 2 (LRRK2) Inhibitors for Parkinson's Disease Treatment23. Calcium calmodulin dependent protein kinase as potential drug target24. Therapeutics of Platelet derived growth factor (PDGF) and signaling in different organs25. EGFRC797S mutation and fourth generation EGFR tyrosine kinase inhibitors (EGFR-TKIs)26. Bacterial Histidine Kinases as potential Antibacterial Drug Targets27. Bacterial Protein Kinases: a target to inhibit the bacterial infections 28. Nanotechnology-based targeted delivery systems for Protein Kinase inhibitors in Cancer therapy